205 related articles for article (PubMed ID: 38118409)
21. Discovery of a selective NLRP3-targeting compound with therapeutic activity in MSU-induced peritonitis and DSS-induced acute intestinal inflammation.
Zhou Y; Yang Z; Ou Y; Cai H; Liu Z; Lin G; Liang S; Hua L; Yan Y; Zhang X; Wu R; Qin A; Hu W; Sun P
Cell Mol Life Sci; 2023 Jul; 80(8):230. PubMed ID: 37498355
[TBL] [Abstract][Full Text] [Related]
22. Structural mechanism for NEK7-licensed activation of NLRP3 inflammasome.
Sharif H; Wang L; Wang WL; Magupalli VG; Andreeva L; Qiao Q; Hauenstein AV; Wu Z; Núñez G; Mao Y; Wu H
Nature; 2019 Jun; 570(7761):338-343. PubMed ID: 31189953
[TBL] [Abstract][Full Text] [Related]
23. Pristimerin protects against inflammation and metabolic disorder in mice through inhibition of NLRP3 inflammasome activation.
Zhao Q; Bi Y; Guo J; Liu YX; Zhong J; Pan LR; Tan Y; Yu XJ
Acta Pharmacol Sin; 2021 Jun; 42(6):975-986. PubMed ID: 32989235
[TBL] [Abstract][Full Text] [Related]
24. NEK7 interacts with NLRP3 to modulate the pyroptosis in inflammatory bowel disease via NF-κB signaling.
Chen X; Liu G; Yuan Y; Wu G; Wang S; Yuan L
Cell Death Dis; 2019 Dec; 10(12):906. PubMed ID: 31787755
[TBL] [Abstract][Full Text] [Related]
25. ZDHHC5-mediated NLRP3 palmitoylation promotes NLRP3-NEK7 interaction and inflammasome activation.
Zheng S; Que X; Wang S; Zhou Q; Xing X; Chen L; Hou C; Ma J; An P; Peng Y; Yao Y; Song Q; Li J; Zhang P; Pei H
Mol Cell; 2023 Dec; 83(24):4570-4585.e7. PubMed ID: 38092000
[TBL] [Abstract][Full Text] [Related]
26. Wolf-Hirschhorn syndrome candidate 1 facilitates alveolar macrophage pyroptosis in sepsis-induced acute lung injury through NEK7-mediated NLRP3 inflammasome activation.
Liu C; Cai B; Li D; Yao Y
Innate Immun; 2021 Aug; 27(6):437-447. PubMed ID: 34428935
[TBL] [Abstract][Full Text] [Related]
27. Theaflavin mitigates acute gouty peritonitis and septic organ injury in mice by suppressing NLRP3 inflammasome assembly.
Chen SY; Li YP; You YP; Zhang HR; Shi ZJ; Liang QQ; Yuan T; Xu R; Xu LH; Zha QB; Ou-Yang DY; He XH
Acta Pharmacol Sin; 2023 Oct; 44(10):2019-2036. PubMed ID: 37221235
[TBL] [Abstract][Full Text] [Related]
28. ALK-JNK signaling promotes NLRP3 inflammasome activation and pyroptosis via NEK7 during Streptococcus pneumoniae infection.
Wang X; Zhao Y; Wang D; Liu C; Qi Z; Tang H; Liu Y; Zhang S; Cui Y; Li Y; Liu R; Shen Y
Mol Immunol; 2023 May; 157():78-90. PubMed ID: 37001294
[TBL] [Abstract][Full Text] [Related]
29. PKA and Epac1 Reduce Nek7 to Block the NLRP3 Inflammasome Proteins in the Retinal Vasculature.
Liu L; Jiang Y; Steinle JJ
Invest Ophthalmol Vis Sci; 2022 Jan; 63(1):14. PubMed ID: 35006270
[TBL] [Abstract][Full Text] [Related]
30. NLRP3 inflammasome inhibitor INF39 attenuated NLRP3 assembly in macrophages.
Shi Y; Lv Q; Zheng M; Sun H; Shi F
Int Immunopharmacol; 2021 Mar; 92():107358. PubMed ID: 33508701
[TBL] [Abstract][Full Text] [Related]
31. Expression of the NEK7/NLRP3 inflammasome pathway in patients with diabetic lower extremity arterial disease.
Cai H; Wang P; Zhang B; Dong X
BMJ Open Diabetes Res Care; 2020 Dec; 8(2):. PubMed ID: 33323459
[TBL] [Abstract][Full Text] [Related]
32. Mst1/2-ALK promotes NLRP3 inflammasome activation and cell apoptosis during Listeria monocytogenes infection.
Gao A; Tang H; Zhang Q; Liu R; Wang L; Liu Y; Qi Z; Shen Y
J Microbiol; 2021 Jul; 59(7):681-692. PubMed ID: 33877580
[TBL] [Abstract][Full Text] [Related]
33. NLRP3 phosphorylation in its LRR domain critically regulates inflammasome assembly.
Niu T; De Rosny C; Chautard S; Rey A; Patoli D; Groslambert M; Cosson C; Lagrange B; Zhang Z; Visvikis O; Hacot S; Hologne M; Walker O; Wong J; Wang P; Ricci R; Henry T; Boyer L; Petrilli V; Py BF
Nat Commun; 2021 Oct; 12(1):5862. PubMed ID: 34615873
[TBL] [Abstract][Full Text] [Related]
34. A Genome-wide CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) Screen Identifies NEK7 as an Essential Component of NLRP3 Inflammasome Activation.
Schmid-Burgk JL; Chauhan D; Schmidt T; Ebert TS; Reinhardt J; Endl E; Hornung V
J Biol Chem; 2016 Jan; 291(1):103-9. PubMed ID: 26553871
[TBL] [Abstract][Full Text] [Related]
35. Carnosic acid inhibits NLRP3 inflammasome activation by targeting both priming and assembly steps.
Lin G; Li N; Li D; Chen L; Deng H; Wang S; Tang J; Ouyang W
Int Immunopharmacol; 2023 Mar; 116():109819. PubMed ID: 36738671
[TBL] [Abstract][Full Text] [Related]
36. Assessment of NLRP3 Inflammasome Activation and NLRP3-NEK7 Complex Assembly.
Kelley N; He Y
Methods Mol Biol; 2023; 2641():17-26. PubMed ID: 37074638
[TBL] [Abstract][Full Text] [Related]
37. Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity.
He H; Jiang H; Chen Y; Ye J; Wang A; Wang C; Liu Q; Liang G; Deng X; Jiang W; Zhou R
Nat Commun; 2018 Jun; 9(1):2550. PubMed ID: 29959312
[TBL] [Abstract][Full Text] [Related]
38. Humans pIKK-up NLRP3 to skip NEK7.
Malireddi RKS; Kanneganti TD
Trends Immunol; 2022 Dec; 43(12):947-949. PubMed ID: 36404209
[TBL] [Abstract][Full Text] [Related]
39. Gallic Acid Alleviates Gouty Arthritis by Inhibiting NLRP3 Inflammasome Activation and Pyroptosis Through Enhancing Nrf2 Signaling.
Lin Y; Luo T; Weng A; Huang X; Yao Y; Fu Z; Li Y; Liu A; Li X; Chen D; Pan H
Front Immunol; 2020; 11():580593. PubMed ID: 33365024
[TBL] [Abstract][Full Text] [Related]
40. NEK7: a new target for the treatment of multiple tumors and chronic inflammatory diseases.
Wang J; Chen S; Liu M; Zhang M; Jia X
Inflammopharmacology; 2022 Aug; 30(4):1179-1187. PubMed ID: 35829941
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
